Form 8-K - Current report:
SEC Accession No. 0001437749-17-015622
Filing Date
2017-09-06
Accepted
2017-09-06 16:02:08
Documents
4
Period of Report
2017-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlcc20170906_8k.htm 8-K 46063
2 EXHIBIT 10.171 ex10-171.htm EX-10.171 84052
3 EXHIBIT 10.172 ex10-172.htm EX-10.172 115915
4 EXHIBIT 10.173 ex10-173.htm EX-10.173 67190
  Complete submission text file 0001437749-17-015622.txt   314649
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55181 | Film No.: 171071368
SIC: 2833 Medicinal Chemicals & Botanical Products